Abstract C119: Characterizing FOXC1 dysregulation in triple-negative breast cancer to advance precision therapies and reduce cancer health disparities
Breast cancer is the most common cancer in women and the second leading cause of cancer death in the United States. Breast cancer has multiple subtypes defined by the expression of the estrogen receptor (ESR1), progesterone receptor (PGR), and human epidermal growth factor receptor 2 (HER2). Among breast cancer subty...